ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Arcus Biosciences at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
Arcus Biosciences brings 2 presentations to ACR Convergence 2026 in Orlando. Its program centres on immune signaling targets, including small-molecule TNF inhibitors that spare regulatory T cells and an IgA-CD89 pathway in severe rheumatoid arthritis.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
Arcus Biosciences Hayward, CA | |
A clinical-stage biopharmaceutical company developing cancer and immunology medicines. | Poster Sun Nov 8 10:30am–12:30pm Poster Sun Nov 8 10:30am–12:30pm |
Find decision makers at Arcus Biosciences
Tell us what you sell and we’ll find the people at Arcus Biosciences most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction